Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

Novartis to Invest $250 Million for R&D of Neglected Tropical Diseases

June 24, 2022

Novartis will endorse the Kigali Declaration on neglected tropical diseases and invest $250 million for R&D.

GSK Announces £1 Billion R&D Investment in Fighting Infectious Diseases in Lower-Income Countries

June 24, 2022

GSK will invest £1 billion in furthering R&D in malaria, tuberculosis, and HIV, as well as neglected tropical diseases.

Avid Bioservices Launches New Analytical and Process Development Suites at Viral Vector Facility

June 21, 2022

Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites.

Orbit Discovery Awarded Innovate UK Grant

June 21, 2022

Orbit Discovery has been awarded the Innovate UK Grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery.

Researchers Invent New Material that Can Capture and Release Biomolecules

June 17, 2022

A new polymer surface material has been invented by researchers in Sweden that uses electrical signals to both capture and release biomolecules.

Precision BioSciences Releases Data on CAR T Therapy Candidates

June 13, 2022

Precision BioSciences has released clinical trial data on CAR T therapy candidates PBCAR0191, PBCAR19B, and PBCAR269A.

Thermo Fisher Scientific and Qatar Genome Program Partner to Advance Precision Medicine

June 03, 2022

Thermo Fisher Scientific and Qatar Genome Program will use custom genotyping arrays to accelerate genomic research in Qatar.

Focusing on the Patient in Drug Development

June 03, 2022

Putting the patient at the forefront of drug development is essential, particularly to ensure medication compliance is optimized.

Development of Coprocessed Excipients

June 03, 2022

The right processes used with the right excipient combinations address evolving formulation needs.

Early Development Challenges in IND Applications

June 03, 2022

Collecting relevant data, planning ahead, and communicating with regulatory bodies in pre-IND meeting programs can help companies to avoid roadblocks in IND applications.